136 related articles for article (PubMed ID: 35111747)
1. MicroRNA-409-3p Targeting at ATXN3 Reduces the Apoptosis of Dopamine Neurons Based on the Profile of miRNAs in the Cerebrospinal Fluid of Early Parkinson's Disease.
Tan X; Hu J; Ming F; Lv L; Yan W; Peng X; Bai R; Xiao Q; Zhang H; Tang B; Wang C; Tan J
Front Cell Dev Biol; 2021; 9():755254. PubMed ID: 35111747
[TBL] [Abstract][Full Text] [Related]
2.
Zhai K; Liu B; Gao L
Hum Gene Ther; 2020 Dec; 31(23-24):1274-1287. PubMed ID: 32808542
[No Abstract] [Full Text] [Related]
3. MicroRNA expressing profiles in A53T mutant alpha-synuclein transgenic mice and Parkinsonian.
Mo M; Xiao Y; Huang S; Cen L; Chen X; Zhang L; Luo Q; Li S; Yang X; Lin X; Xu P
Oncotarget; 2017 Jan; 8(1):15-28. PubMed ID: 27965467
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of SNHG14 Alleviates MPP
Zhou S; Zhang D; Guo J; Zhang J; Chen Y
Front Neurosci; 2020; 14():930. PubMed ID: 33071725
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA nuclear enriched abundant transcript 1 (NEAT1) sponges microRNA-124-3p to up-regulate phosphodiesterase 4B (PDE4B) to accelerate the progression of Parkinson's disease.
Chen MY; Fan K; Zhao LJ; Wei JM; Gao JX; Li ZF
Bioengineered; 2021 Dec; 12(1):708-719. PubMed ID: 33522352
[TBL] [Abstract][Full Text] [Related]
6. miR-494-3p modulates the progression of in vitro and in vivo Parkinson's disease models by targeting SIRT3.
Geng L; Zhang T; Liu W; Chen Y
Neurosci Lett; 2018 May; 675():23-30. PubMed ID: 29567426
[TBL] [Abstract][Full Text] [Related]
7. LncRNA MALAT1 targeting miR-124-3p regulates DAPK1 expression contributes to cell apoptosis in Parkinson's Disease.
Lu Y; Gong Z; Jin X; Zhao P; Zhang Y; Wang Z
J Cell Biochem; 2020 Dec; 121(12):4838-4848. PubMed ID: 32277510
[TBL] [Abstract][Full Text] [Related]
8. miR-29c-3p regulates TET2 expression and inhibits autophagy process in Parkinson's disease models.
Wang R; Yao J; Gong F; Chen S; He Y; Hu C; Li C
Genes Cells; 2021 Sep; 26(9):684-697. PubMed ID: 34086379
[TBL] [Abstract][Full Text] [Related]
9. lncRNA NEAT1 prompts autophagy and apoptosis in MPTP-induced Parkinson's disease by impairing miR-374c-5p.
Dong LI; Zheng Y; Gao L; Luo X
Acta Biochim Biophys Sin (Shanghai); 2021 Jul; 53(7):870-882. PubMed ID: 33984130
[TBL] [Abstract][Full Text] [Related]
10. The Neuroprotective Role of MiR-124-3p in a 6-Hydroxydopamine-Induced Cell Model of Parkinson's Disease via the Regulation of ANAX5.
Dong RF; Zhang B; Tai LW; Liu HM; Shi FK; Liu NN
J Cell Biochem; 2018 Jan; 119(1):269-277. PubMed ID: 28543594
[TBL] [Abstract][Full Text] [Related]
11. LncRNA BDNF-AS promotes autophagy and apoptosis in MPTP-induced Parkinson's disease via ablating microRNA-125b-5p.
Fan Y; Zhao X; Lu K; Cheng G
Brain Res Bull; 2020 Apr; 157():119-127. PubMed ID: 32057951
[TBL] [Abstract][Full Text] [Related]
12. miR-103a-3p regulates mitophagy in Parkinson's disease through Parkin/Ambra1 signaling.
Zhou J; Zhao Y; Li Z; Zhu M; Wang Z; Li Y; Xu T; Feng D; Zhang S; Tang F; Yao J
Pharmacol Res; 2020 Oct; 160():105197. PubMed ID: 32942015
[TBL] [Abstract][Full Text] [Related]
13. LncRNA H19 Attenuates Apoptosis in MPTP-Induced Parkinson's Disease Through Regulating miR-585-3p/PIK3R3.
Zhang Y; Xia Q; Lin J
Neurochem Res; 2020 Jul; 45(7):1700-1710. PubMed ID: 32356199
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-217/138-5p downregulation inhibits inflammatory response, oxidative stress and the induction of neuronal apoptosis in MPP
Wang M; Sun H; Yao Y; Tang X; Wu B
Am J Transl Res; 2019; 11(10):6619-6631. PubMed ID: 31737212
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-599 regulates the development of Parkinson's disease through mediating LRRK2 expression.
Wu Q; Xi DZ; Wang YH
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):724-731. PubMed ID: 30720180
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of long non-coding RNA AL049437 mitigates MPP+ -induced neuronal injury in SH-SY5Y cells via the microRNA-205-5p/MAPK1 axis.
Zhang L; Wang J; Liu Q; Xiao Z; Dai Q
Neurotoxicology; 2020 May; 78():29-35. PubMed ID: 32057949
[TBL] [Abstract][Full Text] [Related]
17. Unveiling the regulatory of miR-101-3p on ZNF746 in a Parkinson's disease cell model: Implications for therapeutic targeting.
Mahmoudian Esfahani M; Mostashfi M; Vaheb Hosseinabadi S; Hashemi MS; Peymani M; Zohrabi D; Angaji SA; Nasr-Esfahani MH; Ghaedi K
Neurosci Res; 2024 Jun; 203():18-27. PubMed ID: 38103579
[TBL] [Abstract][Full Text] [Related]
18. Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease.
Gui Y; Liu H; Zhang L; Lv W; Hu X
Oncotarget; 2015 Nov; 6(35):37043-53. PubMed ID: 26497684
[TBL] [Abstract][Full Text] [Related]
19. MiR-29c protects against inflammation and apoptosis in Parkinson's disease model in vivo and in vitro by targeting SP1.
Wang R; Yang Y; Wang H; He Y; Li C
Clin Exp Pharmacol Physiol; 2020 Mar; 47(3):372-382. PubMed ID: 31732967
[TBL] [Abstract][Full Text] [Related]
20. Hypothesis: Do miRNAs Targeting the Leucine-Rich Repeat Kinase 2 Gene (LRRK2) Influence Parkinson's Disease Susceptibility?
Yılmaz ŞG; Geyik S; Neyal AM; Soko ND; Bozkurt H; Dandara C
OMICS; 2016 Apr; 20(4):224-8. PubMed ID: 27093107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
